Logo

Celgene Collaborates with Exscientia for its AI Drug Discovery Platform

Share this

Celgene Collaborates with Exscientia for its AI Drug Discovery Platform

Shots:

  • Celgene & Exscientia enter into a 3yrs. partnership to accelerate the development of small molecules for three therapeutic programs for Celgene using Exscientia’s Centaur Chemist AI drug discovery platform in oncology & autoimmunity
  • Exscientia to receive $25M upfront & regulatory & commercial milestone on a future sale of products resulting from the collaboration
  • Exscientia’s Centaur Chemist platform improves drug efficacy & speed of delivery of new treatments. Exscientia also collaborated with GSK- Sanofi- Roche- and Evotec for its AI technology

Click here to read full press release/ article | Ref: Exscientia | Image: Endpoints News


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions